ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 167 filers reported holding ANIKA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $758,706 | -76.1% | 40,725 | -66.7% | 0.00% | -100.0% |
| Q2 2023 | $3,174,600 | -13.1% | 122,194 | -4.0% | 0.00% | 0.0% |
| Q1 2023 | $3,654,821 | +92732.6% | 127,257 | -4.3% | 0.00% | -33.3% |
| Q4 2022 | $3,937 | -99.9% | 133,013 | +11.4% | 0.00% | +50.0% |
| Q3 2022 | $2,842,000 | +27.4% | 119,391 | +19.5% | 0.00% | 0.0% |
| Q2 2022 | $2,230,000 | -11.1% | 99,908 | 0.0% | 0.00% | +100.0% |
| Q1 2022 | $2,509,000 | -0.8% | 99,908 | +41.5% | 0.00% | 0.0% |
| Q4 2021 | $2,529,000 | +65.0% | 70,587 | +96.0% | 0.00% | 0.0% |
| Q3 2021 | $1,533,000 | +7.7% | 36,012 | +9.6% | 0.00% | 0.0% |
| Q2 2021 | $1,423,000 | +5.3% | 32,861 | -0.9% | 0.00% | 0.0% |
| Q1 2021 | $1,352,000 | +14.7% | 33,151 | +27.3% | 0.00% | 0.0% |
| Q4 2020 | $1,179,000 | +15.2% | 26,040 | -10.0% | 0.00% | 0.0% |
| Q3 2020 | $1,023,000 | -25.0% | 28,918 | -20.0% | 0.00% | 0.0% |
| Q2 2020 | $1,364,000 | +15.7% | 36,152 | -11.4% | 0.00% | 0.0% |
| Q1 2020 | $1,179,000 | -49.4% | 40,796 | -9.2% | 0.00% | -50.0% |
| Q4 2019 | $2,329,000 | -47.2% | 44,909 | -44.1% | 0.00% | -60.0% |
| Q3 2019 | $4,413,000 | +35.2% | 80,400 | +0.0% | 0.01% | +25.0% |
| Q2 2019 | $3,265,000 | -28.8% | 80,390 | -44.0% | 0.00% | +33.3% |
| Q1 2019 | $4,588,000 | +83.9% | 143,427 | +93.2% | 0.00% | 0.0% |
| Q4 2018 | $2,495,000 | -16.3% | 74,224 | +5.0% | 0.00% | -25.0% |
| Q3 2018 | $2,981,000 | +2.5% | 70,678 | -22.2% | 0.00% | 0.0% |
| Q2 2018 | $2,908,000 | -43.2% | 90,881 | -11.8% | 0.00% | -42.9% |
| Q1 2018 | $5,121,000 | -14.9% | 102,987 | -7.8% | 0.01% | -12.5% |
| Q4 2017 | $6,021,000 | -1.8% | 111,694 | +5.7% | 0.01% | -11.1% |
| Q3 2017 | $6,132,000 | +53.6% | 105,716 | +30.7% | 0.01% | +50.0% |
| Q2 2017 | $3,992,000 | +31.0% | 80,904 | +15.3% | 0.01% | +20.0% |
| Q1 2017 | $3,047,000 | +5.1% | 70,153 | +18.4% | 0.01% | 0.0% |
| Q4 2016 | $2,900,000 | -35.3% | 59,234 | -36.8% | 0.01% | -37.5% |
| Q3 2016 | $4,484,000 | +47.2% | 93,715 | +62.4% | 0.01% | +33.3% |
| Q2 2016 | $3,047,000 | +9.1% | 57,719 | 0.0% | 0.01% | +20.0% |
| Q1 2016 | $2,792,000 | +418.0% | 57,719 | +308.7% | 0.01% | +400.0% |
| Q4 2015 | $539,000 | – | 14,124 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 44,875 | $2,031,000 | 2.14% |
| Parian Global Management LP | 102,705 | $4,648,000 | 1.16% |
| CAPITAL MANAGEMENT CORP /VA | 93,035 | $4,211,000 | 1.15% |
| Avidity Partners Management LP | 731,000 | $33,085,000 | 1.07% |
| Sio Capital Management, LLC | 65,382 | $2,959,000 | 0.61% |
| DIKER MANAGEMENT LLC | 21,835 | $988,000 | 0.50% |
| Archon Capital Management LLC | 48,925 | $2,214,000 | 0.38% |
| Caption Management, LLC | 362,800 | $16,420,000 | 0.37% |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 1,546,260 | $69,984,000 | 0.20% |
| Boston Trust Walden Corp | 378,167 | $17,116,000 | 0.18% |